Zhao Wu
Beijing, 100034, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Virtual differential phase-contrast and dark-field imaging of x-ray absorption images via deep learning.
Journal: Bioengineering & translational medicine
Published: February 28, 2022
Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial.
Journal: International immunopharmacology
Published: January 26, 2021
Significant Histologic Changes Are Not Rare in Treatment-naive Hepatitis B Patients with Normal Alanine Aminotransferase Level: A Meta-analysis.
Journal: Journal of clinical and translational hepatology
Published: November 30, 2020
Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 16, 2020
Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.
Journal: Journal of medical virology
Published: July 14, 2020
Diverse clinical processes of 16 COVID-19 cases who concentrated infection in the same workplace in Beijing, China: An observational study.
Journal: Medicine
Published: June 09, 2020
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.
Journal: International journal of antimicrobial agents
Published: February 26, 2020
Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study.
Journal: Chinese medical journal
Published: November 15, 2019
Last Updated: 09/26/2026